J. Alvir

发表

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects

J. Lieberman, B. Bogerts, M. Ashtari, 2002, Biological Psychiatry.

Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia

J. Lieberman, B. Bogerts, M. Ashtari, 1990, Psychiatry Research: Neuroimaging.

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.

J. Lieberman, J. Kane, M. Chakos, 1995, The American journal of psychiatry.

Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

J. Lieberman, R. Bilder, D. Robinson, 1999, The American journal of psychiatry.

Longitudinal study of brain morphology in first episode schizophrenia

J. Lieberman, R. Bilder, D. Robinson, 2001, Biological Psychiatry.

Reliability of DSM-IV Symptom Ratings of ADHD

J. Alvir, M. Solanto, 2009, Journal of attention disorders.

Trinucleotide repeat length instability and age of onset in Huntington's disease

J. Penney, S. Folstein, A. Falek, 1993, Nature Genetics.

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.

J. Lieberman, J. Schaaf, J. Alvir, 1993, The New England journal of medicine.

Computed Tomographic‐Angiographic Findings Within the First Five Hours of Cerebral Infarction

J L Zito, J. Alvir, J Alvir, 1991, Stroke.

Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Karen Marder, Norman Arnheim, Ira Shoulson, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research

R. Willke, B. Jones, J. Alvir, 2011, Journal of managed care pharmacy : JMCP.

Incidence and correlates of acute extrapyramidal symptoms in first episode schizophrenia

J. Lieberman, B. Sheitman, M. Chakos, 1995, Schizophrenia Research.

Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates.

J. Lieberman, D. Levy, B. Bogerts, 1993, Archives of general psychiatry.

Negative Symptoms in Schizophrenia: Relationship to Positive Symptoms and Outcome

J. Lieberman, B. Bogerts, M. Ashtari, 1991 .

Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital.

J. Lieberman, D. Levy, B. Bogerts, 1992, Schizophrenia bulletin.

Logical memory subtest of the Wechsler Memory Scale: age and education norms and alternate-form reliability of two scoring systems.

H. Abikoff, J. Alvir, S. Saravay, 1987, Journal of clinical and experimental neuropsychology.

Health Care Utilization and Costs in Patients with Generalized Anxiety Disorder Initiating Add-on Therapy with Benzodiazepines

G. Oster, V. Bollu, A. Joshi, 2012 .

Patient-Reported Outcomes: Measurement, Implementation and Interpretation

K. Zou, J. Cappelleri, T. Symonds, 2013 .

School-Based Intervention for Adolescents with Social Anxiety Disorder: Results of a Controlled Study

P. H. Fisher, Carrie Masia-Warner, R. Klein, 2005, Journal of abnormal child psychology.

Suboptimal adherence to prescribed daily growth hormone regimen among medicaid beneficiaries in the United States

P. Jhingran, J. Alvir, J. Loftus, 2022, Current medical research and opinion.

Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.

I. Creese, F. Tarazi, R. Bilder, 1999, Life Science.

Efficacy of Meta-Cognitive Therapy (MCT) for Adult ADHD

H. Abikoff, D. Marks, J. Alvir, 2013 .

Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “Real-World Data”

E. Perfetto, R. Willke, P. Subedi, 2011, Journal of Managed Care Pharmacy : JMCP.

Table of Contents Examination of Data , Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “ Real-World Data ”

E. Perfetto, R. Willke, P. Subedi, 2011 .

The prevalence of tardive dyskinesia.

J. Lieberman, M. Borenstein, J. Kane, 1991, Journal of clinical psychopharmacology.

The hypothalamic-pituitary-adrenal system in panic disorder.

J. Endicott, G. Asnis, J. Alvir, 1987, The American journal of psychiatry.

Incidence and Correlates of Tardive Dyskinesia in First Episode of Schizophrenia

J. Lieberman, M. Borenstein, J. Kane, 1996 .

Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial

M. Stewart, J. Alvir, Benjamin Li, 2020, Cardiology and Therapy.

Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy.

J. Lieberman, J. Kane, S. Mukherjee, 1989, Archives of general psychiatry.

Correlates of substance misuse in patients with first‐episode schizophrenia and schizoaffective disorder

J. Lieberman, R. Bilder, D. Robinson, 2001 .

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

J. Lieberman, R. Bilder, D. Robinson, 2001, Acta psychiatrica Scandinavica.

Methylphenidate Response, Psychopathology and Tardive Dyskinesia as Predictors of Relapse in Schizophrenia

J. Lieberman, T. Cooper, J. Kane, 1994, Neuropsychopharmacology.

Diabetes and development of tardive dyskinesia.

J. Lieberman, J. Kane, M. Woerner, 1993, The American journal of psychiatry.

Treatment outcome of first episode schizophrenia.

J. Lieberman, J. Walsleben, M. Woerner, 1989, Psychopharmacology bulletin.

Ethics of Drug Discontinuation Studies in Schizophrenia-Reply

J. Lieberman, J. Kane, M. Woerner, 1989 .

Reduced Bone Mass in Women With Premenstrual Syndrome

S. Goldsmith, J. Alvir, S. Thys-Jacobs, 1995 .

' s response to reviews Title : Healthcare utilization and costs in patients with schizophrenia or bipolar disorder receiving aripiprazole , quetiapine , or ziprasidone at hospital discharge : A retrospective cohort study

G. Oster, J. Alvir, J. Edelsberg, 2012 .

Thyroid releasing hormone test in schizophrenic patients with post-psychotic depression

S. Siris, J. Alvir, K. Frechen, 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Obstetric complications predict treatment response in first-episode schizophrenia

J. Lieberman, M. Woerner, G. Degreef, 1999, Psychological Medicine.

in Panic Disorder

J. Endicott, G. Asnis, J. Alvir, 1987 .

Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia

Jeffrey A. Lieberman, Robert M. Bilder, Bernhard Bogerts, 1995, Schizophrenia Research.

Conditions that mimic stroke in the emergency department. Implications for acute stroke trials.

J. Alvir, J Alvir, R. Libman, 1995, Archives of neurology.

455 Shape analysis of hippocampus in schizophrenia

M. Ashtari, R. Bilder, R. Strous, 1997, Schizophrenia Research.

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

J. Lieberman, R. Bilder, D. Robinson, 2000, The American journal of psychiatry.

Neuroleptic treatment of elderly patients.

J. Lieberman, J. Kane, M. Woerner, 1995, Psychopharmacology bulletin.

Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.

K. Rascati, A. Goddard, J. Alvir, 2011, Psychiatric services.

Adjunctive imipramine maintenance in post-psychotic depression/negative symptoms.

S. Siris, J. Alvir, S. Mason, 1990, Psychopharmacology bulletin.

Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B.

B. Tortella, A. Pleil, J. Alvir, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

J. Lieberman, R. Bilder, D. Robinson, 1999, Archives of general psychiatry.

Time course and biologic correlates of treatment response in first-episode schizophrenia.

J. Lieberman, M. Borenstein, M. Woerner, 1993, Archives of general psychiatry.

Duration of psychosis and outcome in first-episode schizophrenia.

J. Lieberman, J. Alvir, S. Szymanski, 1992, The American journal of psychiatry.

Correlates of course and outcome in first-episode schizophrenia

J. Lieberman, M. Borenstein, J. Alvir, 1991, Schizophrenia Research.

Provocative tests with psychostimulant drugs in schizophrenia

J. Lieberman, J. Kane, J. Alvir, 2004, Psychopharmacology.

Premenstrual and menstrual symptom clusters and response to calcium treatment.

J. Alvir, S. Thys-Jacobs, S. Thys‐Jacobs, 1991, Psychopharmacology bulletin.

Prediction of relapse in schizophrenia.

J. Lieberman, J. Kane, M. Woerner, 1987, Archives of general psychiatry.

Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.

J. Lieberman, M. Chakos, F. Amin, 1994, Archives of general psychiatry.

Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects.

J. Lieberman, D. Robinson, B. Sheitman, 2004, Schizophrenia bulletin.

Prospective study of tardive dyskinesia in the elderly: rates and risk factors.

J. Lieberman, J. Kane, M. Woerner, 1998, The American journal of psychiatry.

Dr. Robinson and Colleagues Reply

J. Lieberman, D. Robinson, M. Chakos, 1995 .

Patient‐reported reasons for discontinuing overactive bladder medication

J. Benner, M. Nichol, J. Trocio, 2010, BJU international.

Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals

Ira Shoulson, Jose Alvir, J. Penney, 1990, Movement disorders : official journal of the Movement Disorder Society.

Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder

J. Lieberman, R. Bilder, D. Robinson, 2002, Schizophrenia Research.

Calcium supplementation in premenstrual syndrome

A. Bierman, J. Alvir, H. Weisman, 1989, Journal of General Internal Medicine.

Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients.

M Ashtari, J. Lieberman, B. Bogerts, 1992, Archives of general psychiatry.

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment

J. Piercy, P. Taylor, R. Caporali, 2018, RMD Open.

A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective

P. Taylor, J. Alvir, M. Tarallo, 2016, Rheumatology International.

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

Jose Alvir, A. Sadosky, J. Alvir, 2010, PAIN®.

Absence of regional hemispheric volume asymmetries in first-episode schizophrenia.

M Ashtari, J. Lieberman, B. Bogerts, 1994, The American journal of psychiatry.

The deficit state in first-episode schizophrenia.

J. Lieberman, M. Borenstein, J. Alvir, 1994, The American journal of psychiatry.

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.

J. Lieberman, J. Kane, B. Sheitman, 1995, The American journal of psychiatry.

A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience.

J. Lieberman, J. Alvir, 1994, Journal of Clinical Psychopharmacology.

Mood responses of remitted schizophrenics to methylphenidate infusion

J. Lieberman, D. Robinson, T. Cooper, 2005, Psychopharmacology.

Psychobiologic Correlates of Treatment Response in Schizophrenia

J. Lieberman, B. Sheitman, M. Chakos, 1996, Neuropsychopharmacology.

Qualitative assessment of brain morphology in acute and chronic schizophrenia.

J. Lieberman, B. Bogerts, M. Ashtari, 1992, The American journal of psychiatry.

Agranulocytosis: incidence and risk factors.

J. Lieberman, J. Alvir, 1994, The Journal of clinical psychiatry.

Clozapine as a first treatment for schizophrenia.

J. Lieberman, D. Robinson, J. Kane, 2003, The American journal of psychiatry.

Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder.

M Ashtari, B. Bogerts, M. Ashtari, 1999, Archives of general psychiatry.

Reduced caudate nucleus volume in obsessive-compulsive disorder.

M Ashtari, B. Bogerts, M. Ashtari, 1995, Archives of general psychiatry.

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

Manzar Ashtari, Jose Alvir, J. Lieberman, 1995, The Lancet.

Adjunctive imipramine for dysphoric schizophrenic patients with past histories op cannabis abuse

S. Siris, J. Alvir, S. Mason, 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The Behavioral Effect of m-Chlorophenylpiperazine (mCPP) and Methylphenidate in First-Episode Schizophrenia and Normal Controls

J. Lieberman, M. Chakos, J. Alvir, 1995, Neuropsychopharmacology.

Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia.

J. Lieberman, J. Alvir, S. Szymanski, 1990, Psychopharmacology bulletin.

Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency

J. Alvir, J. Loftus, L. Chi, 2021, Current medical research and opinion.

Developing cognitive‐social‐emotional competencies to enhance academic learning

Jose Alvir, H. Abikoff, J. Alvir, 2005 .

Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.

J. Lieberman, R. Bilder, B. Sheitman, 1996, The Journal of clinical psychiatry.

Brain morphology in first episode schizophrenia

J. Lieberman, B. Bogerts, M. Ashtari, 1991, Schizophrenia Research.

Financial and clinical characteristics of fibromyalgia: a case-control comparison.

A. Palacio, J. Alvir, C. Uribe, 2010, The American journal of managed care.

The Clinical and Economic Burden of Newly Diagnosed Alzheimer’s Disease in a Medicare Advantage Population

Sonali N. Shah, B. Suehs, A. Joshi, 2013, American journal of Alzheimer's disease and other dementias.

The impact of menopausal symptoms on quality of life, productivity, and economic outcomes.

M. Dibonaventura, Sonali N. Shah, J. Alvir, 2013, Journal of women's health.

Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers

W. Lenderking, M. Stewart, S. Shaffer, 2018, Neurology and Therapy.

Toward characterization and definition of fibromyalgia severity

S. Silverman, G. Zlateva, A. Sadosky, 2010, BMC musculoskeletal disorders.

Depression in first-episode schizophrenia.

J. Lieberman, M. Chakos, S. Siris, 1993, The American journal of psychiatry.

Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans.

C. Mullins, J. Margolis, A. Joshi, 2010, The American journal of managed care.

Effects of a Medicaid prior authorization policy for pregabalin.

C. Mullins, J. Margolis, S. Johnston, 2009, The American journal of managed care.

Health Care Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries

L. Shulman, J. Alvir, E. Onukwugha, 2021, Neurology.

Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.

Jose Alvir, S. Sevy, H. Gunduz-Bruce, 2005, The Journal of clinical psychiatry.

Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity

H. Kraemer, J. Swanson, W. Pelham, 2002, Journal of abnormal child psychology.

Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

M. Stewart, J. Alvir, D. Keohane, 2018, Neurology and Therapy.

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia

A. Palacio, J. Alvir, C. Uribe, 2011, Current medical research and opinion.

Efficacy of meta-cognitive therapy for adult ADHD.

H. Abikoff, D. Marks, J. Alvir, 2010, The American journal of psychiatry.

Adherence, Persistence of Use, and Costs Associated With Second-Generation Antipsychotics for Bipolar Disorder

K. Rascati, A. Goddard, J. Alvir, 2011 .

Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice

J. Piercy, P. Taylor, R. Caporali, 2018, Patient preference and adherence.

Prospective study of tardive dyskinesia incidence in the elderly.

J. Lieberman, J. Kane, K. Blank, 1991, JAMA.

Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study

G. Oster, M. Treglia, J. Alvir, 2012, BMC Psychiatry.

Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study

G. Oster, V. Bollu, A. Joshi, 2011, BMC psychiatry.

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data

J. Alvir, E. Pappadopulos, C. Deshpande, 2016, Neuropsychiatric disease and treatment.

The efficacy of cognitive–behavioral therapy for older adults with ADHD: a randomized controlled trial

J. Alvir, M. Solanto, C. Surman, 2018, ADHD Attention Deficit and Hyperactivity Disorders.

Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.

D. Revicki, J. Alvir, N. Brandenburg, 2008, Journal of pain and symptom management.

Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls

J. Lieberman, N. Mendell, D. Levy, 1993, Biological Psychiatry.

Incidence and correlates of tardive dyskinesia in first episode schizophrenia

J. Lieberman, R. Bilder, M. Chakos, 1995, Schizophrenia Research.

Cross‐National Burden of Painful Diabetic Peripheral Neuropathy in Asia, Latin America, and the Middle East

A. Sadosky, J. Alvir, D. Hoffman, 2009, Pain practice : the official journal of World Institute of Pain.

What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia

Jose Alvir, Sube Banerjee, Sube Banerjee, 2009, International journal of geriatric psychiatry.

Infant television and video exposure associated with limited parent-child verbal interactions in low socioeconomic status households.

Catherine S Tamis-LeMonda, Jose Alvir, Benard P Dreyer, 2008, Archives of pediatrics & adolescent medicine.

Evidence for sensitization in the early stage of schizophrenia

J. Lieberman, J. Alvir, D. Mayerhoff, 1992, Schizophrenia Research.

PIH32 THE ASSOCIATION OF MENOPAUSAL SYMPTOMS, INCLUDING HOT FLASHES, WITH QUALITY OF LIFE, WORK PRODUCTIVITY AND RESOURCE USE

M. Dibonaventura, Sonali N. Shah, J. Alvir, 2011 .

Comparative analysis of three PMS assessment instruments--the identification of premenstrual syndrome with core symptoms.

J. Alvir, P. Fratarcangelo, S. Thys-Jacobs, 1995, Psychopharmacology bulletin.

Outcome assessment of an antipsychotic drug algorithm: effects of the Mississippi State Hospital algorithm project.

B. Cuffel, J. Alvir, K. Sanders, 2011, Psychiatric services.

Household Members of Persons with Alzheimer's Disease: Health Conditions, Healthcare Resource Use, and Healthcare Costs

Sonali N. Shah, B. Suehs, N. Patel, 2014, Journal of the American Geriatrics Society.

Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.

J. Alvir, J. Bobula, L. Lacey, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study

G. Oster, J. Alvir, J. Edelsberg, 2012, BMC Psychiatry.

Do white-cell count spikes predict agranulocytosis in clozapine recipients?

J. Lieberman, J. Alvir, A. Safferman, 1995, Psychopharmacology bulletin.

Characterizing Disease Burden in an Ultra-Rare Disease in the United States: Transthyretin (TTR) Amyloidosis Patients & Caregivers

M. Stewart, S. Shaffer, J. Alvir, 2013 .

Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia.

S. Johnston, M. Udall, J. Alvir, 2014, Pain medicine.

Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.

J. Lieberman, J. Kane, M. Chakos, 1994, The American journal of psychiatry.

Incidence of Tardive Dyskinesia with Risperidone or Olanzapine in the Elderly: Results from a 2-Year, Prospective Study in Antipsychotic-Naïve Patients

C. Correll, J. Kane, H. Delman, 2011, Neuropsychopharmacology.

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy

M. Stewart, J. Alvir, D. Keohane, 2015, Orphanet Journal of Rare Diseases.

Methylphenidate and neuroleptic effects on oral word production in schizophrenia

J. Lieberman, R. Bilder, J. Alvir, 1992 .

Development of drug-induced parkinsonism in elderly individuals receiving neuroleptics for the first time

J. Kane, J. Lieberman, J. Alvir, 1991, Schizophrenia Research.

A Retrospective Study of Clinical and Economic Burden of Focal Segmental Glomerulosclerosis (FSGS) in the United States

K. Kalantar-Zadeh, N. Tamimi, S. Berasi, 2021, Kidney international reports.